155k views
1 vote
The client receives filgrastim (Neupogen). He asks the nurse, "That is such a funny name; where do you suppose it comes from?" What is the best response by the nurse?

1. "It comes from the interleukins it stimulates; this one stimulates neuocytes."
2. "It comes from the blood cell it stimulates; this one stimulates neutrophils."
3. "It comes from the stem cells it stimulates, such as filgrastims."
4. "It is a complicated process; the drug companies are secretive about it."

User Rmpestano
by
7.4k points

1 Answer

0 votes

Final Answer:

The best response by the nurse is option 2: "It comes from the blood cell it stimulates; this one stimulates neutrophils."

Step-by-step explanation:

Filgrastim, commonly known as Neupogen, is a medication that belongs to a class of drugs called granulocyte colony-stimulating factors (G-CSF). G-CSFs stimulate the production of specific white blood cells, particularly neutrophils, in the bone marrow. Neutrophils play a crucial role in the immune system, helping to fight off infections. Therefore, the nurse's response aligns with the pharmacological mechanism of filgrastim.

In option 2, the nurse provides a clear and accurate explanation to the client, connecting the drug to its intended effect on blood cells. Neutrophils are a type of white blood cell that defends the body against bacterial and fungal infections. This response not only answers the client's question but also imparts relevant information about the drug's therapeutic action.

Understanding the drug's mechanism of action is vital for both healthcare providers and patients, as it enhances medication adherence and facilitates informed decision-making. In this context, the nurse's concise and accurate response promotes patient education and engagement in their healthcare journey.

In summary, option 2 is the best response as it directly addresses the client's question, providing a succinct and accurate explanation of filgrastim's origin and its role in stimulating neutrophil production.

User Colt McAnlis
by
7.7k points